Navigation Links
AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
Date:10/22/2007

BENICIA, Calif., Oct. 22 /PRNewswire/ -- AcroMetrix, the leading provider of quality control standards for clinical diagnostic and blood testing laboratories, announced that they have enhanced their OptiQuant HIV-1 Quantification Panel to be the first to utilize an EDTA-based normal human plasma matrix. This product is for Research Use Only, not for use in diagnostic procedures.

This new matrix, called OptiMatrix, allows the OptiQuant HIV-1 panel to most closely mimic a patient sample. The commutability of the OptiQuant HIV panel ensures accurate comparison and compatibility between a wide variety of testing platforms globally. As a further improvement, AcroMetrix panel members are the first to be directly traceable to International Units per milliliter (IU/mL) to facilitate global quality through ISO standards.

"The OptiQuant HIV-1 Quantification Panel represents our commitment to standardization in diagnostics," said Michael J. Eck, President and CEO. "The new OptiQuant panel is the first HIV validation panel available to be traceable to the WHO standard, in a truly commutable matrix."

This new OptiQuant HIV Panel fully complies with the ISO 17511:2003 (In vitro diagnostic medical devices -- Measurement of quantities in biological samples -- Metrological traceability of values assigned to calibrators and control materials) standard. Through the ISO 17511 standard, AcroMetrix aims to facilitate a uniform global quality control network by producing consistent and traceable universal standards.

"Our goal is to standardize diagnostic testing so that a patient can receive a truly comparable test result regardless of the doctor or laboratory they choose to visit," said Mr. Eck, "The new OptiQuant HIV panel is a step in that direction for HIV viral load testing."

About AcroMetrix

AcroMetrix, with facilities in Benicia, California and Alkmaar, the Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com.


'/>"/>
SOURCE AcroMetrix
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
2. State of Diabetes in Pittsburgh: Pittsburgh Business Group on Health Releases Report
3. Analyzers Offer Point-of-Care Lipid Panels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):